Andrew Hollman Meyer
CIK: 0001864159
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Janux Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Jan 2, 2026JANX
Janux Therapeutics, Inc.
Sale(S)Direct1.9K shares at avg. $13.73$26K - Dec 1, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct3.3K shares at avg. $10.59$35K - Dec 1, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $32.85$89K - Dec 1, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct633 shares at avg. $33.52$21K - Nov 14, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct3.3K shares at avg. $10.59$35K - Nov 14, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $30.00$100K - Oct 28, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct10K shares at avg. $4.21$42K - Oct 28, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct6.7K shares at avg. $10.59$71K - Oct 28, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct16.7K shares at avg. $30.06$501K - May 1, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct2.9K shares at avg. $31.95$94K - May 1, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct400 shares at avg. $32.60$13K - May 1, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct3.3K shares at avg. $4.21$14K - Apr 21, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $30.00$100K - Apr 21, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct3.3K shares at avg. $4.21$14K - Mar 3, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct901 shares at avg. $32.85$30K - Mar 3, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct3.3K shares at avg. $4.21$14K - Mar 3, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct2.4K shares at avg. $31.88$78K - Feb 3, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct2.4K shares at avg. $42.08$102K - Feb 3, 2025JANX
Janux Therapeutics, Inc.
Exercise(M)Direct3.3K shares at avg. $4.21$14K - Feb 3, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct100 shares at avg. $43.60$4K - Feb 3, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct816 shares at avg. $42.77$35K - Jan 2, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct5.8K shares at avg. $54.51$314K - Jan 2, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct3.4K shares at avg. $55.76$192K - Jan 2, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct1K shares at avg. $56.78$57K - Jan 2, 2025JANX
Janux Therapeutics, Inc.
Sale(S)Direct200 shares at avg. $57.37$11K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | JANX Janux Therapeutics, Inc. | Sale(S) | 1,879 | $13.73 | $25,799 | Direct |
| Dec 1, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 3,333 | $10.59 | $35,296 | Direct |
| Dec 1, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 2,700 | $32.85 | $88,708 | Direct |
| Dec 1, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 633 | $33.52 | $21,221 | Direct |
| Nov 14, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 3,333 | $10.59 | $35,296 | Direct |
| Nov 14, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 3,333 | $30.00 | $99,990 | Direct |
| Oct 28, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 9,999 | $4.21 | $42,096 | Direct |
| Oct 28, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 6,666 | $10.59 | $70,593 | Direct |
| Oct 28, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 16,665 | $30.06 | $500,987 | Direct |
| May 1, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 2,933 | $31.95 | $93,703 | Direct |
| May 1, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 400 | $32.60 | $13,041 | Direct |
| May 1, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 3,333 | $4.21 | $14,032 | Direct |
| Apr 21, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 3,334 | $30.00 | $100,020 | Direct |
| Apr 21, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 3,334 | $4.21 | $14,036 | Direct |
| Mar 3, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 901 | $32.85 | $29,599 | Direct |
| Mar 3, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 3,334 | $4.21 | $14,036 | Direct |
| Mar 3, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 2,433 | $31.88 | $77,576 | Direct |
| Feb 3, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 2,418 | $42.08 | $101,739 | Direct |
| Feb 3, 2025 | JANX Janux Therapeutics, Inc. | Exercise(M) | 3,334 | $4.21 | $14,036 | Direct |
| Feb 3, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 100 | $43.60 | $4,360 | Direct |
| Feb 3, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 816 | $42.77 | $34,901 | Direct |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 5,768 | $54.51 | $314,420 | Direct |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 3,444 | $55.76 | $192,033 | Direct |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 1,000 | $56.78 | $56,778 | Direct |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | Sale(S) | 200 | $57.37 | $11,473 | Direct |
1-25 of 31 transactions
About Meyer Andrew Hollman
Meyer Andrew Hollman (SEC CIK 0001864159) files insider reports with the SEC as Chief Business Officer of Janux Therapeutics, Inc. (JANX).
Signal8 holds 11 ownership filings by Meyer Andrew Hollman, all Form 4s, filed between Sep 27, 2024 and Jan 2, 2026. Those filings report 31 transactions, from Sep 27, 2024 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Meyer Andrew Hollman's filings is in SAN DIEGO, CA.
Recent filings by Meyer Andrew Hollman
- Jan 2, 2026: Open-market sale of JANX shares (Form 4, code S).
- Dec 1, 2025: Option exercise of JANX shares (Form 4, code M).
- Dec 1, 2025: Open-market sales of JANX shares (2 lines, Form 4, code S).
- Nov 14, 2025: Option exercise of JANX shares (Form 4, code M).
- Nov 14, 2025: Open-market sale of JANX shares (Form 4, code S).
Other insiders filing for Janux Therapeutics, Inc. (JANX)
- Campbell David Alan, President and CEO
- RA CAPITAL MANAGEMENT, L.P., Director
- Simson Jake, Director
- Kung Winston, Director
- Hernday Natasha, Director
- DOBMEIER ERIC, Director